Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term DAPT After Bioabsorbable Polymer Everolimus-eluting Stent
NCT03447379Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Dec 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of clopidogrel and ticagrelor in coronary artery disease (CAD) (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoints: Major adverse cardiovascular clinical events and Major bleeding. Started Dec 2017; status: completed.
02
Drugs
clopidogrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03447379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447379.